Your browser doesn't support javascript.
loading
Does a Vagal Response Indicate Cardiac Autonomic Modulation and Improve the Therapeutic Effect of Pulmonary Vein Isolation in Patients with Paroxysmal Atrial Fibrillation? Insights from Cryoballoon Ablation.
Kiedrowicz, Radoslaw M; Wielusinski, Maciej; Zakrzewski, Marcin; Kazmierczak, Jaroslaw.
Affiliation
  • Kiedrowicz RM; Cardiology Department, Pomeranian Medical University, Powstancow Wlkp. 72, 70-111 Szczecin, Poland.
  • Wielusinski M; Cardiology Department, Pomeranian Medical University, Powstancow Wlkp. 72, 70-111 Szczecin, Poland.
  • Zakrzewski M; Cardiology Department, Pomeranian Medical University, Powstancow Wlkp. 72, 70-111 Szczecin, Poland.
  • Kazmierczak J; Cardiology Department, Pomeranian Medical University, Powstancow Wlkp. 72, 70-111 Szczecin, Poland.
J Cardiovasc Dev Dis ; 9(5)2022 May 02.
Article in En | MEDLINE | ID: mdl-35621853
ABSTRACT

Background:

The incidence and influence of vagal response (VR) observed during cryoballoon-based pulmonary vein isolation (CBA-based PVI) on the cardiac autonomic nervous system (CANS) and ablation outcomes in paroxysmal atrial fibrillation (PAF) remain unknown.

Methods:

296 patients were treated with a 28 mm second-generation cryoballoon (Medtronic). A total of 74 patients without structural heart disease and concomitant diseases were chosen for a detailed CANS assessment with a heart rate variability (HRV) analysis. All patients were screened over a 2-year post-ablation period.

Results:

VR was detected in 30% of patients and included sinus arrest (64%) or severe sinus bradycardia (46%). The presence of VR was not related to PV ostial dimension, patient clinical characteristics or intraprocedural ablation details. CANS modulation, manifesting as increased median HR and decreased HRV parameters with intact sympatho-vagal balance occurred independently of VR presence or absence and sustained for at least 12 months following ablation. VR was not related with more intensive CANS modulation and did not translate into better ablation outcomes when compared to the non-VR group (74% vs. 71% at 12 months and 69% vs. 65% at 24 months respectively).

Conclusions:

VR is frequent during CBA-based PVI for PAF and unrelated to any additional clinical benefit.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Cardiovasc Dev Dis Year: 2022 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Cardiovasc Dev Dis Year: 2022 Document type: Article Affiliation country: